Sugi Predict

Sugi Predict / Compounds / SCHEMBL6337381

SCHEMBL6337381

SCHEMBL6337381

NC(=O)c1ccc2sccc2c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ PTK2 Q05397 1/20 0.39
▸ ERN1 O75460 1/20 0.39
▸ MAPK10 P53779 3/20 0.38
▸ MAPK8 P45983 4/20 0.37
▸ JUN P05412 1/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ GPR35 Q9HC97 1/20 0.36
▸ HSD17B10 Q99714 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ XDH P47989 1/20 0.33
▸ SLC22A12 Q96S37 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3936083 0.83 LDHA (0.47) ALDH1A1MAPTKMT2AMEN1MAPK1
SCHEMBL6283230 0.77 CA12 (0.46) ALDH1A1MAPTKMT2AMEN1MAPK10
SCHEMBL827310 0.76 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AMEN1MAPK1
SCHEMBL30745208 0.76 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AMEN1MAPK1
SCHEMBL23459940 0.74 CA12 (0.50) ALDH1A1MAPTKMT2AMEN1HSD17B10
SCHEMBL3424158 0.72 ERN1 (0.54) ALDH1A1MAPTKMT2AMEN1MAPK1
SCHEMBL30211643 0.72 ERN1 (0.54) ALDH1A1MAPTKMT2AMEN1MAPK1
SCHEMBL30753169 0.69 MAPK1 (0.44) ALDH1A1MAPTKMT2AMEN1MAPK1
SCHEMBL26337401 0.69 MAPK1 (0.44) ALDH1A1MAPTKMT2AMEN1MAPK1
SCHEMBL14113158 0.68 MAPT (0.42) ALDH1A1MAPTKMT2AMEN1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903097-B2 Heterocycle carboxamides as antiviral agents PHARMACIA & UPJOHN COMPANY (US) 2005-06-07 — — US disclosed
US-20040142928-A1 Heterocycle carboxamides as antiviral agents BUNDY GORDON L (US) 2004-07-22 — — US disclosed
US-20030207880-A1 Heterocycle carboxamides as antiviral agents BUNDY GORDON L (US) 2003-11-06 — — US disclosed
US-6559145-B2 Herpes virus PHARMACIA & UPJOHN COMPANY 2003-05-06 — — US disclosed
EP-1301493-A2 HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-04-16 — — EP disclosed
US-20020025960-A1 Heterocycle carboxamides as antiviral agents PHARMACIA & UPJOHN COMPANY 2002-02-28 — — US disclosed
WO-2002004444-A2 HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2002-01-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142928-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 ALDH1A1 779/4885MAPT 4388/4885KMT2A 993/4885
US-20020025960-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 ALDH1A1 779/4885MAPT 4388/4885KMT2A 993/4885
US-20030207880-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 ALDH1A1 779/4885MAPT 4388/4885KMT2A 993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.